• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用胸水NT-氨基末端脑钠肽前体浓度鉴别猫心源性和非心源性胸腔积液。

Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations.

作者信息

Humm K, Hezzell M, Sargent J, Connolly D J, Boswood A

机构信息

Veterinary Clinical Sciences, The Royal Veterinary College, North Mymms, Hatfield.

出版信息

J Small Anim Pract. 2013 Dec;54(12):656-61. doi: 10.1111/jsap.12152. Epub 2013 Nov 7.

DOI:10.1111/jsap.12152
PMID:24283418
Abstract

OBJECTIVE

To assess whether pleural fluid and urine amino terminal proB-type natriuretic peptide (NT-proBNP) can distinguish cardiac from non-cardiac causes of pleural effusion.

METHODS

Blood, urine and pleural fluid were prospectively collected from cats presenting with pleural effusion categorised as cardiac or non-cardiac in origin. NT-ProBNP concentrations were measured using a feline-specific enzyme-linked immunosorbent assay. Groups were statistically compared and receiver operating characteristic curves constructed to determine cut-offs to distinguish cardiac from non-cardiac pleural effusion in plasma, pleural fluid and urine.

RESULTS

Forty cats with pleural effusion (22 cardiac and 18 non-cardiac) were studied. NT-proBNP concentrations in plasma and pleural fluid were strongly correlated. Plasma (P<0·001) and pleural fluid (P<0·001) NT-proBNP concentrations and urinary NT-proBNT/creatinine ratios (P=0·035) were significantly higher in the cardiac group. After receiver operating characteristic curve analysis a plasma NT-proBNP cut-off of 214·3 pmol/mL was suggested [sensitivity=86·4% (95% CI: 66·7 to 95·3%), specificity=88·9% (95% CI: 67·2 to 96·9%)] and a pleural fluid NT-proBNP cut-off of 322·3 pmol/mL was suggested [sensitivity=100% (95% CI: 85·1 to 100%), specificity=94·4% (95% CI: 74·2 to 99·0%)]. No cut-off with adequate sensitivity and specificity for urinary NT-proBNP/creatinine ratios was suggested.

CLINICAL SIGNIFICANCE

Measurement of NT-proBNP in pleural fluid distinguishes cardiac from non-cardiac causes of pleural effusion in cats.

摘要

目的

评估胸腔积液和尿液氨基末端B型利钠肽原(NT-proBNP)能否区分胸腔积液的心脏源性和非心脏源性病因。

方法

前瞻性收集因胸腔积液就诊的猫的血液、尿液和胸腔积液,将胸腔积液分为心脏源性或非心脏源性。使用猫特异性酶联免疫吸附测定法测量NT-ProBNP浓度。对各组进行统计学比较,并构建受试者工作特征曲线以确定区分血浆、胸腔积液和尿液中心脏源性与非心脏源性胸腔积液的临界值。

结果

研究了40只患有胸腔积液的猫(22只为心脏源性,18只为非心脏源性)。血浆和胸腔积液中的NT-proBNP浓度密切相关。心脏源性组的血浆(P<0.001)和胸腔积液(P<0.001)NT-proBNP浓度以及尿液NT-proBNT/肌酐比值(P=0.035)显著更高。经过受试者工作特征曲线分析,建议血浆NT-proBNP临界值为214.3 pmol/mL[灵敏度=86.4%(95%CI:66.7至95.3%),特异性=88.9%(95%CI:67.2至96.9%)],胸腔积液NT-proBNP临界值为322.3 pmol/mL[灵敏度=100%(95%CI:85.1至100%),特异性=94.4%(95%CI:74.2至99.0%)]。未提出对尿液NT-proBNP/肌酐比值具有足够灵敏度和特异性的确切临界值。

临床意义

测量胸腔积液中的NT-proBNP可区分猫胸腔积液的心脏源性和非心脏源性病因。

相似文献

1
Differentiating between feline pleural effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations.利用胸水NT-氨基末端脑钠肽前体浓度鉴别猫心源性和非心源性胸腔积液。
J Small Anim Pract. 2013 Dec;54(12):656-61. doi: 10.1111/jsap.12152. Epub 2013 Nov 7.
2
Differentiation of Cardiac from Noncardiac Pleural Effusions in Cats using Second-Generation Quantitative and Point-of-Care NT-proBNP Measurements.使用第二代定量和即时检测NT-proBNP测量法鉴别猫的心源性与非心源性胸腔积液
J Vet Intern Med. 2016 Mar-Apr;30(2):536-42. doi: 10.1111/jvim.13831. Epub 2016 Jan 27.
3
Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.评估一种用于区分猫胸腔积液的心脏性与非心脏性病因的N末端B型利钠肽原(NT-proBNP)床旁检测方法。
BMC Vet Res. 2017 Dec 20;13(1):394. doi: 10.1186/s12917-017-1319-6.
4
Assessment of circulating N-terminal pro B-type natriuretic peptide concentration to differentiate between cardiac from noncardiac causes of pleural effusion in cats.评估循环中N末端B型利钠肽原浓度以鉴别猫胸腔积液的心脏性与非心脏性病因
J Vet Emerg Crit Care (San Antonio). 2013 Jul-Aug;23(4):416-22. doi: 10.1111/vec.12074. Epub 2013 Jul 16.
5
Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.血清和胸腔积液N末端B型利钠肽原浓度在胸腔积液鉴别诊断中的应用
Tuberk Toraks. 2011;59(1):1-7.
6
Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria.比较血清和胸腔积液中脑钠肽前体(NT-proBNP)水平与胸腔积液-血清白蛋白梯度,以识别被Light标准误分类的心脏积液。
Respirology. 2007 Sep;12(5):654-9. doi: 10.1111/j.1440-1843.2007.01109.x.
7
High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.N末端B型利钠肽原对胸腔积液心脏源性的诊断准确性高。
Eur Respir J. 2006 Jul;28(1):144-50. doi: 10.1183/09031936.06.00113205. Epub 2006 Feb 15.
8
Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.胸腔积液患者胸腔液中的氨基末端脑利钠肽。
Respir Care. 2013 Feb;58(2):313-9. doi: 10.4187/respcare.01818.
9
Comparison of pleural N-terminal pro-B-type natriuretic peptide, midregion pro-atrial natriuretic peptide and mid-region pro-adrenomedullin for the diagnosis of pleural effusions associated with cardiac failure.比较胸腔积液 N 末端 pro-B 型利钠肽、中段 pro 心房利钠肽和中段 pro 肾上腺髓质素在诊断与心力衰竭相关的胸腔积液中的作用。
Respirology. 2013 Apr;18(3):540-5. doi: 10.1111/resp.12039.
10
Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.胸腔积液 N-末端脑利钠肽前体和脑利钠肽-32 肽水平的比较。
Chest. 2010 Jun;137(6):1369-74. doi: 10.1378/chest.09-2193. Epub 2010 Feb 5.

引用本文的文献

1
Utility of the Ratio between Lactate Dehydrogenase (LDH) Activity and Total Nucleated Cell Counts in Effusions (LDH/TNCC Ratio) for the Diagnosis of Feline Infectious Peritonitis (FIP).乳酸脱氢酶(LDH)活性与积液中总核细胞计数之比(LDH/TNCC比值)在猫传染性腹膜炎(FIP)诊断中的应用。
Animals (Basel). 2022 Aug 31;12(17):2262. doi: 10.3390/ani12172262.
2
Retrospective analysis of radiographic signs in feline pleural effusions to predict disease aetiology.回顾性分析猫胸腔积液的影像学征象,以预测疾病病因。
BMC Vet Res. 2022 Mar 26;18(1):118. doi: 10.1186/s12917-022-03218-3.
3
The Feline Cardiomyopathies: 1. General concepts.
猫心肌病:1. 一般概念。
J Feline Med Surg. 2021 Nov;23(11):1009-1027. doi: 10.1177/1098612X211021819.
4
Evaluation of pleural fluid parameters related to cardiac diseases in cats.猫心脏疾病相关胸腔积液参数的评估
Vet World. 2021 Aug;14(8):2238-2243. doi: 10.14202/vetworld.2021.2238-2243. Epub 2021 Aug 27.
5
Updates on Laboratory Evaluation of Feline Cardiac Diseases.猫心脏疾病实验室评估的最新进展。
Vet Sci. 2021 Mar 3;8(3):41. doi: 10.3390/vetsci8030041.
6
Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫二尖瓣收缩期前向运动时的生物标志物变化
J Vet Intern Med. 2020 Sep;34(5):1718-1727. doi: 10.1111/jvim.15807. Epub 2020 Aug 21.
7
ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats.ACVIM 共识声明指南:猫心肌病的分类、诊断和管理。
J Vet Intern Med. 2020 May;34(3):1062-1077. doi: 10.1111/jvim.15745. Epub 2020 Apr 3.
8
Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.猫的特征对血浆 N-末端前脑钠肽 B 型利钠肽浓度的影响及即时检测与 ELISA 检测的比较。
J Vet Intern Med. 2020 May;34(3):1187-1197. doi: 10.1111/jvim.15754. Epub 2020 Mar 22.
9
Retrospective analysis of pleural effusion in cats.猫胸腔积液的回顾性分析。
J Feline Med Surg. 2019 Dec;21(12):1102-1110. doi: 10.1177/1098612X18816489. Epub 2018 Dec 17.
10
Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.评估一种用于区分猫胸腔积液的心脏性与非心脏性病因的N末端B型利钠肽原(NT-proBNP)床旁检测方法。
BMC Vet Res. 2017 Dec 20;13(1):394. doi: 10.1186/s12917-017-1319-6.